| Name | Title | Contact Details |
|---|
OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.
Integrated Behavioral Health (IBH) provides innovative technology based tools and effective treatments for employee assistance, workers compensation programs, substance abuse and opioid addiction, behavioral health, and wellness management. For over 35 years, IBH serves over 38K employers and supports 10 million employees and their families. With a focus on positive outcomes through clinically validated methods and tools, IBH reduces claims and costs for organizations while improving the lives of its people.
Wolters Kluwer Health is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
St. Peter's Health Care Services is a Albany, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Meadowbrook Manor is a Bolingbrook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.